Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-05T05:35:52.545Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbapenem-Resistant Enterobacteriaceae Rectal Screening during an Outbreak of New Delhi Metallo-β-Lactamase–Producing Klebsiella pneumoniae at an Acute Care Hospital

Published online by Cambridge University Press:  10 May 2016

Larissa M. Pisney ,
M. A. Barron ,
E. Kassner ,
D. Havens  and
N. E. Madinger
Larissa M. Pisney*
Affiliation:
Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado
M. A. Barron
Affiliation:
Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado
E. Kassner
Affiliation:
Clinical Microbiology Laboratory, University of Colorado Hospital, Aurora, Colorado
D. Havens
Affiliation:
Clinical Microbiology Laboratory, University of Colorado Hospital, Aurora, Colorado
N. E. Madinger
Affiliation:
Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado Clinical Microbiology Laboratory, University of Colorado Hospital, Aurora, Colorado
*
University of Colorado Denver, 12700 East 19th Avenue, B168, Aurora, CO 80045 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the results of carbapenem-resistant Enterobacteriaceae (CRE) screening as part of an outbreak investigation of New Delhi metallo-β-lactamase–producing CRE at a tertiary care university teaching hospital. The manual method for CRE screening was useful for detecting patients with asymptomatic CRE carriage but was time-consuming and costly.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 4: Special Topic Issue: Carbapenem-Resistant Enterobacteriaceae and Multidrug-Resistant Organisms , April 2014 , pp. 434 - 436
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.Google Scholar
2. Borer, A, Saidel-Odes, L, Riesenberg, K, et al. Attributable mortality rare for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972–976.Google Scholar
3. Giske, CG, Monnett, DL, Cars, O, Carmeli, Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813–821.CrossRefGoogle ScholarPubMed
4. Yong, D, Toleman, MA, Giske, CG, Cho, HS, Sundman, K, Lee, K, Walsh, TR. Characterization of a new metallo-beta-lactamase gene, bla NDM-1˒ and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046–5054.Google Scholar
5. Walsh, TR, Weeks, J, Livermore, DM, Toleman, MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2001;11:355–362.Google Scholar
6. Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148ra116.CrossRefGoogle ScholarPubMed
7. Centers for Disease Control and Prevention (CDC). Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE). Atlanta: CDC, 2012. http://www.cdc.gov/hai/pdfs/cre/cre-guidance-508.pdf. Accessed October 10, 2013.Google Scholar
8. Centers for Disease Control and Prevention (CDC). Laboratory Protocol for Detection of Carbapenem-Resistant or Carbapenemase-Producing, Klebsiella spp. and E. coli from Rectal Swabs. Atlanta: CDC. http://www.cdc.gov/HAI/pdfs/labSettings/Klebsiella_or_Ecoli.pdf. Accessed October 10, 2013.Google Scholar
9. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. Wayne, PA: CLSI, 2012. CLSI document M100-S22.Google Scholar
10. Centers for Disease Control and Prevention (CDC). Multiplex Real-Time PCR Detection of Klebsiella pneumoniae Carbapenemase (KPC) and New Delhi Metallo-β-Lactamase (NDM-1). Atlanta: CDC, 2011. http://www.cdc.gov/HAI/pdfs/labSettings/KPC-NDM-protocol-2011.pdf. Accessed October 10, 2013.Google Scholar
11. Landman, D, Salvani, JK, Bratu, S, Quale, J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005;43:5639–5641.Google Scholar
12. Borgia, S, Lastovetska, O, Richardson, D, et al. Outbreak of carbapenem-resistant Enterobacteriaceae containing bla NDM-1˒ Ontario, Canada. Clin Infect Dis 2012;55:e109–e117.Google Scholar
13. Wilkinson, KM, Winstanley, TG, Lanyon, C, Cummings, SP, Raza, MW, Perry, JD. Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae . J Clin Microbiol 2012;50:3102–3104.Google Scholar